Literature DB >> 8821479

Developmental expression of dystrophin, dystrophin-associated glycoproteins and other membrane cytoskeletal proteins in human skeletal and heart muscle.

M Mora1, C Di Blasi, R Barresi, L Morandi, B Brambati, L Jarre, F Cornelio.   

Abstract

Dystrophin, utrophin and the dystrophin-associated glycoproteins, beta-dystroglycan and adhalin, were analyzed, together with the membrane cytoskeletal proteins beta-spectrin, vinculin and talin, and adult and fetal myosin heavy chains, in 25 normal human fetuses from 8 to 24 weeks of gestation. Dystrophin was present in heart and skeletal muscle from 8 weeks although in the latter was mainly in the cytoplasm at this stage. Utrophin expression increased until around gestational weeks 19/21, but by 24 weeks immunostaining and immunoblot band intensities had reduced. Beta-dystroglycan was scarce in skeletal muscle at 8 weeks, increased with maturation and was more abundant in heart of the same age. Adhalin appeared later than beta-dystroglycan on skeletal muscle fiber surfaces, positivity became more intense as the fibers matured. In heart adhalin was detectable only in groups of cells at 12-16 weeks. From 8 weeks all fetal myotubes expressed beta-spectrin on their surfaces, while vinculin and talin positivity was mainly at the periphery of the fascicles, increasing with age. Adult slow myosin was seen in most myotubes at 10 weeks. Secondary myotubes then formed which increasingly expressed adult fast myosin, while still retaining fetal myosin. By 24 weeks most fibers expressing adult slow myosin had lost fetal myosin and were more mature in the expression of most membrane proteins. Muscle membrane organization during human fetal development is a complex process and takes place earlier in heart than skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821479     DOI: 10.1016/0165-3806(95)00169-7

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  7 in total

Review 1.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

2.  Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.

Authors:  J Manuel Pioner; Xuan Guan; Jordan M Klaiman; Alice W Racca; Lil Pabon; Veronica Muskheli; Jesse Macadangdang; Cecilia Ferrantini; Michael R Hoopmann; Robert L Moritz; Deok-Ho Kim; Chiara Tesi; Corrado Poggesi; Charles E Murry; Martin K Childers; David L Mack; Michael Regnier
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

Review 3.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

4.  In vivo dynamics of skeletal muscle Dystrophin in zebrafish embryos revealed by improved FRAP analysis.

Authors:  Fernanda Bajanca; Vinicio Gonzalez-Perez; Sean J Gillespie; Cyriaque Beley; Luis Garcia; Eric Theveneau; Richard P Sear; Simon M Hughes
Journal:  Elife       Date:  2015-10-13       Impact factor: 8.140

5.  Subtle neuromuscular defects in utrophin-deficient mice.

Authors:  R M Grady; J P Merlie; J R Sanes
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

Review 6.  Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy.

Authors:  Josè Manuel Pioner; Alessandra Fornaro; Raffaele Coppini; Nicole Ceschia; Leonardo Sacconi; Maria Alice Donati; Silvia Favilli; Corrado Poggesi; Iacopo Olivotto; Cecilia Ferrantini
Journal:  Front Physiol       Date:  2020-05-12       Impact factor: 4.566

7.  Full-length dystrophin deficiency leads to contractile and calcium transient defects in human engineered heart tissues.

Authors:  Samantha B Bremner; Christian J Mandrycky; Andrea Leonard; Ruby M Padgett; Alan R Levinson; Ethan S Rehn; J Manuel Pioner; Nathan J Sniadecki; David L Mack
Journal:  J Tissue Eng       Date:  2022-08-17       Impact factor: 7.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.